Using a prospective registry of patients with aortic stenosis, Lindman et al. [134] showed that a multiple biomarker model constructed from sST2 together with BNP and galectin-3 was more predictive of 1-year and 2-year mortality rates in patients undergoing TAVR than either biomarker alone. This evidence concerns the gene NPPB and aortic stenosis.